While consumers have been increasingly interested in CBD, regulatory concerns may have producers taking different paths to market or exploring alternative ingredients.Consumers are seeking more natural ways to address health challenges such as increased stress levels, sleep concerns, inflammation and much more. In recent years, this has seen a boom of products introduced containing hemp extracts, isolated cannabinoids, and related ingredients that can impact the body’s endocannabinoid system. This month, Vitafoods Insights focuses on cannabinoids and CBD, including whitespace, regulatory challenges, and research on efficacy.Tune in to hear more about:How the endocannabinoid system regulates body functions from cognition to inflammationConcerns around the evolving regulatory market for cannabinoidsWhy palmitoylethaolamide (PEA), an endocannabinoid-like lipid mediator, may offer a different route to marketProduct quality and research as a cornerstone to delivering efficacious productsHarvard Health BlogGrand View ResearchHost: Heather Granato, vice president, content, VitafoodsGuests:Mariko Hill, global innovation manager, Gencor PacificMatteo Delbruck, CEO, Swiss Organic PartnersSponsored by: Gencor and Swiss Organic PartnersClick here to listen to our other Thematic Podcast episodes If you like the show, make sure to subscribe and follow the Vitafoods Insights podcast. Feel free also to recommend the show to a friend that you think would enjoy it.For more content from Vitafoods Insights, make sure to check our website:  https://www.vitafoodsinsights.com   To learn more about sponsorships opportunities, click here and make sure to check our media kit.

Ver todos los episodios